Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

102 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Excessive antigen reactivity may underlie the clinical aggressiveness of chronic lymphocytic leukemia stereotyped subset #8.
Gounari M, Ntoufa S, Apollonio B, Papakonstantinou N, Ponzoni M, Chu CC, Rossi D, Gaidano G, Chiorazzi N, Stamatopoulos K, Ghia P. Gounari M, et al. Among authors: papakonstantinou n. Blood. 2015 Jun 4;125(23):3580-7. doi: 10.1182/blood-2014-09-603217. Epub 2015 Apr 21. Blood. 2015. PMID: 25900981 Free PMC article. Clinical Trial.
B Cell Anergy Modulated by TLR1/2 and the miR-17∼92 Cluster Underlies the Indolent Clinical Course of Chronic Lymphocytic Leukemia Stereotyped Subset #4.
Ntoufa S, Papakonstantinou N, Apollonio B, Gounari M, Galigalidou C, Fonte E, Anagnostopoulos A, Belessi C, Muzio M, Ghia P, Stamatopoulos K. Ntoufa S, et al. Among authors: papakonstantinou n. J Immunol. 2016 May 15;196(10):4410-7. doi: 10.4049/jimmunol.1502297. Epub 2016 Apr 8. J Immunol. 2016. PMID: 27059597
Integrated epigenomic and transcriptomic analysis reveals TP63 as a novel player in clinically aggressive chronic lymphocytic leukemia.
Papakonstantinou N, Ntoufa S, Tsagiopoulou M, Moysiadis T, Bhoi S, Malousi A, Psomopoulos F, Mansouri L, Laidou S, Papazoglou D, Gounari M, Pasentsis K, Plevova K, Kuci-Emruli V, Duran-Ferrer M, Davis Z, Ek S, Rossi D, Gaidano G, Ritgen M, Oscier D, Stavroyianni N, Pospisilova S, Davi F, Ghia P, Hadzidimitriou A, Belessi C, Martin-Subero JI, Pott C, Rosenquist R, Stamatopoulos K. Papakonstantinou N, et al. Int J Cancer. 2019 Jun 1;144(11):2695-2706. doi: 10.1002/ijc.31999. Epub 2019 Jan 15. Int J Cancer. 2019. PMID: 30447004
Inhibition of EZH2 and immune signaling exerts synergistic antitumor effects in chronic lymphocytic leukemia.
Chartomatsidou E, Ntoufa S, Kotta K, Rovida A, Akritidou MA, Belloni D, Ferrero E, Trangas T, Stavroyianni N, Anagnostopoulos A, Rosenquist R, Ghia P, Papakonstantinou N, Stamatopoulos K. Chartomatsidou E, et al. Among authors: papakonstantinou n. Blood Adv. 2019 Jun 25;3(12):1891-1896. doi: 10.1182/bloodadvances.2018030262. Blood Adv. 2019. PMID: 31227476 Free PMC article.
RPS15 mutations rewire RNA translation in chronic lymphocytic leukemia.
Ntoufa S, Gerousi M, Laidou S, Psomopoulos F, Tsiolas G, Moysiadis T, Papakonstantinou N, Mansouri L, Anagnostopoulos A, Stavrogianni N, Pospisilova S, Plevova K, Makris AM, Rosenquist R, Stamatopoulos K. Ntoufa S, et al. Among authors: papakonstantinou n. Blood Adv. 2021 Jul 13;5(13):2788-2792. doi: 10.1182/bloodadvances.2020001717. Blood Adv. 2021. PMID: 34251413 Free PMC article.
The TΑp63/BCL2 axis represents a novel mechanism of clinical aggressiveness in chronic lymphocytic leukemia.
Laidou S, Grigoriadis D, Papanikolaou S, Foutadakis S, Ntoufa S, Tsagiopoulou M, Vatsellas G, Anagnostopoulos A, Kouvatsi A, Stavroyianni N, Psomopoulos F, Makris AM, Agelopoulos M, Thanos D, Chatzidimitriou A, Papakonstantinou N, Stamatopoulos K. Laidou S, et al. Among authors: papakonstantinou n. Blood Adv. 2022 Apr 26;6(8):2646-2656. doi: 10.1182/bloodadvances.2021006348. Blood Adv. 2022. PMID: 35235952 Free PMC article.
Toll-like receptor signaling pathway in chronic lymphocytic leukemia: distinct gene expression profiles of potential pathogenic significance in specific subsets of patients.
Arvaniti E, Ntoufa S, Papakonstantinou N, Touloumenidou T, Laoutaris N, Anagnostopoulos A, Lamnissou K, Caligaris-Cappio F, Stamatopoulos K, Ghia P, Muzio M, Belessi C. Arvaniti E, et al. Among authors: papakonstantinou n. Haematologica. 2011 Nov;96(11):1644-52. doi: 10.3324/haematol.2011.044792. Epub 2011 Jul 12. Haematologica. 2011. PMID: 21750087 Free PMC article. Clinical Trial.
Distinct innate immunity pathways to activation and tolerance in subgroups of chronic lymphocytic leukemia with distinct immunoglobulin receptors.
Ntoufa S, Vardi A, Papakonstantinou N, Anagnostopoulos A, Aleporou-Marinou V, Belessi C, Ghia P, Caligaris-Cappio F, Muzio M, Stamatopoulos K. Ntoufa S, et al. Among authors: papakonstantinou n. Mol Med. 2012 Dec 6;18(1):1281-91. doi: 10.2119/molmed.2011.00480. Mol Med. 2012. PMID: 22437326 Free PMC article.
102 results